Effector Memory CD8+ and CD4+ T Cell Immunity Associated with Metabolic Syndrome in Obese Children
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: We investigated the association of effector memory (EM) CD8+ T cell and CD4+ T cell immunity with metabolic syndrome (MS). Methods: Surface and intracellular staining of peripheral blood mononuclear cells was performed. Anti-interleukin-7 receptor-alpha (IL-7Rα) and CX3CR1 antibodies were used to stain the subsets of EM CD8+ T cells, while anti-interferon-gamma (IFN-γ), interleukin-17 (IL-17), and forkhead box P3 (FOXP3) antibodies were used for CD4+ T cell subsets. Results: Of the 47 obese children, 11 were female. Children with MS had significantly higher levels of serum insulin (34.8±13.8 vs. 16.4±6.3 μU/mL, p<0.001) and homeostasis model assessment of insulin resistance (8.9±4.1 vs. 3.9±1.5, p<0.001) than children without MS. Children with MS revealed significantly higher frequencies of IL-7Rαlow CD8+ T cells (60.1 ±19.1% vs. 48.4±11.5%, p=0.047) and IL-7RαlowCX3CR1+ CD8+ T cells (53.8±20.1% vs. 41.5 ±11.9%, p=0.036) than children without MS. As the serum triglyceride levels increased, the frequency of IL-7RαlowCX3CR1+ and IL-7RαhighCX3CR1– CD8+ T cells increased and decreased, respectively (r=0.335, p=0.014 and r=−0.350, p=0.010, respectively), in 47 children. However, no CD4+ T cell subset parameters were significantly different between children with and without MS. Conclusion: In obese children with MS, the changes in immunity due to changes in EM CD8+ T cells might be related to the morbidity of obesity.
Abstract
Purpose: We investigated the association of effector memory (EM) CD8+ T cell and CD4+ T cell immunity with metabolic syndrome (MS). Methods: Surface and intracellular staining of peripheral blood mononuclear cells was performed. Anti-interleukin-7 receptor-alpha (IL-7Rα) and CX3CR1 antibodies were used to stain the subsets of EM CD8+ T cells, while anti-interferon-gamma (IFN-γ), interleukin-17 (IL-17), and forkhead box P3 (FOXP3) antibodies were used for CD4+ T cell subsets. Results: Of the 47 obese children, 11 were female. Children with MS had significantly higher levels of serum insulin (34.8±13.8 vs. 16.4±6.3 μU/mL, p<0.001) and homeostasis model assessment of insulin resistance (8.9±4.1 vs. 3.9±1.5, p<0.001) than children without MS. Children with MS revealed significantly higher frequencies of IL-7Rαlow CD8+ T cells (60.1 ±19.1% vs. 48.4±11.5%, p=0.047) and IL-7RαlowCX3CR1+ CD8+ T cells (53.8±20.1% vs. 41.5 ±11.9%, p=0.036) than children without MS. As the serum triglyceride levels increased, the frequency of IL-7RαlowCX3CR1+ and IL-7RαhighCX3CR1– CD8+ T cells increased and decreased, respectively (r=0.335, p=0.014 and r=−0.350, p=0.010, respectively), in 47 children. However, no CD4+ T cell subset parameters were significantly different between children with and without MS. Conclusion: In obese children with MS, the changes in immunity due to changes in EM CD8+ T cells might be related to the morbidity of obesity.
참고문헌 (20)
- "Prevalence of obesity among children and adolescents" (2020)[URL]
- 강기수, "Nutritional Counseling for Obese Children with Obesity-Related Metabolic Abnormalities in Korea", Pediatric Gastroenterology, Hepatology & Nutrition, 20(2), pp.71~78 (2017), 대한소아소화기영양학회
- Friend A, "The prevalence of metabolic syndrome in children : a systematic review of the literature", Metab Syndr Relat Disord, 11, pp.71~80 (2013)
- Helen H. Wang, "Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome", Pediatric Gastroenterology, Hepatology & Nutrition, 23(3), pp.189~230 (2020), 대한소아소화기영양학회[DOI]
- Zimmet P, "The metabolic syndrome in children and adolescents-an IDF consensus report", Pediatr Diabetes, 8, pp.299~306 (2007)
- Guzmán-Flores JM, "Th17 and regulatory T cells in patients with different time of progression of type 2 diabetes mellitus", Cent Eur J Immunol, 45, pp.29~36 (2020)
- Wang M, "Th17 and Treg lymphocytes in obesity and Type 2 diabetic patients", Clin Immunol, 197, pp.77~85 (2018)
- Jung C, "Alterations in systemic levels of Th1, Th2, and Th17 cytokines in overweight adolescents and obese mice", Pediatr Diabetes, 18, pp.714~721 (2017)
- Sell H, "Adaptive immunity in obesity and insulin resistance", Nat Rev Endocrinol, 8, pp.709~716 (2012)
- Odegaard JI, "Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance", Nature, 447, pp.1116~1120 (2007)
- Tiemessen MM, "CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes", macrophages, 2007, pp.104, 19446~19451
- Nishimura S, "CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity", Nat Med, 15, pp.914~920 (2009)
- Sultan A, "T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice", Circ Res, 104, pp.961~968 (2009)
- Kim HR, "Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses", Blood, 107, pp.2855~2862 (2006)
- Kim HR, "Down-regulation of IL-7Ralpha expression in human T cells via DNA methylation", J Immunol, 178, pp.5473~5479 (2007)
- Shin MS, "DNA methylation regulates the differential expression of CX3CR1 on human IL-7Rαlow and IL-7Rαhigh effector memory CD8+ T cells with distinct migratory capacities to the fractalkine", J Immunol, 195, pp.2861~2869 (2015)
- Liu H, "Fractalkine", CX3CR1 and atherosclerosis, 2011, pp.412, 1180~1186
- Min-Su Oh, "Associations among the Degree of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, Degree of Obesity in Children, and Parental Obesity", Pediatric Gastroenterology, Hepatology & Nutrition, 19(3), pp.199~206 (2016), 대한소아소화기영양학회
- Min-Su Oh, "Factors associated with Advanced Bone Age in Overweight and Obese Children", Pediatric Gastroenterology, Hepatology & Nutrition, 23(1), pp.89~97 (2020), 대한소아소화기영양학회[DOI]
- Surendar J, "Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome(CURES-103)", Diabetes Technol Ther, 13, pp.477~482 (2011)
